Access to world-class cancer care is no longer limited by geography. Patients can now obtain an online second opinion from U.S. top doctors at leading hospitals such as Dana-Farber, MD Anderson, and Memorial Sloan Kettering. These experts provide insights into FDA-approved advanced treatments, including targeted therapies, immunotherapies, and novel clinical trial drugs, often unavailable outside the U.S. Through platforms like Medebound HEALTH.

Pulmonary cancer patients worldwide face barriers to accessing the latest treatments and expert care. The United States leads in advanced therapies, precision medicine, and minimally invasive surgeries for this disease. Medebound HEALTH connects international patients with top U.S. pulmonary oncologists for rapid second opinions, often within 1–2 weeks. This guide explores the leading American hospitals for pulmonary cancer care and how global patients can benefit from their

Getting a second medical opinion can take weeks or even months, but timely access is vital for serious conditions. This article explains typical wait times, common delays, and practical tips to speed the process. With good preparation and telemedicine, patients can often secure expert guidance in just 1–2 weeks.

Glioblastoma is among the most aggressive brain cancers, but care from top U.S. doctors can expand treatment options and improve outcomes. This article explains why the U.S. leads in glioblastoma care, the challenges for international patients, and how telemedicine and online second opinions bridge the gapbillustrated by a real patient case.

Author: Medical Editor Iris Content Introduction: When Local Treatments Fall Short for Pediatric Epilepsy Why U.S. Pediatric Neurologists Are Leaders in Epilepsy Care Challenges of Accessing U.S.-Standard Epilepsy Care When You Can’t Travel Abroad Second Opinion From the U.S. – A Game-Changer Without a Medical Tour Can You Access U.S. Expertise Without Medical Travel? Yes, You Can Real Case: How a Remote Second Opinion Changed a Child’s Life Top U.S. Hospitals for Pediatric E

This article highlights how a 68-year-old man with Alzheimer's disease accessed expert U.S. care remotely through Medebound HEALTH after local treatments failed. Featuring a second opinion from a Cornell-affiliated neurologist and access to the FDA-approved drug Leqembi, the case underscores how families worldwide can now receive advanced Alzheimer’s care—without leaving home. The piece also reviews top U.S.

A 33-year-old woman in Asia facing a recurrent yolk sac tumor received a potentially life-saving treatment plan through a cross-border consultation between MD Anderson Cancer Center in the U.S. and PUMCH in Beijing. Facilitated by Medebound HEALTH, the collaboration resulted in a personalized recommendation for high-dose chemotherapy and stem cell transplantation, offering new hope for a rare and aggressive cancer.

Soft tissue sarcoma is a rare cancer affecting muscles, fat, and connective tissues, with varied survival outcomes depending on stage and treatment. Early diagnosis and expert care are crucial, especially for Asian patients facing access barriers. This article explores sarcoma types, survival rates, treatment options, and real patient cases. It also highlights how Medebound HEALTH connects Asian patients with top U.S. cancer specialists through virtual second opinions.

This blog compares second opinion services from MD Anderson, MSK, and Medebound HEALTH for cancer care, focusing on Asian patients. It highlights MD Anderson’s in-person consultations, MSK’s remote and in-person options, and Medebound’s virtual platform with multilingual record integration, instant messaging, and Director-level specialists. Medebound’s premium, culturally sensitive service offers a hassle-free, rapid solution, ideal for Asian families seeking top-tier experti

Connect with America's leading cancer experts via secure video consultations. Get treatment guidance from MSKCC specialists.